We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The 2025 ADA Standards of Care includes updated ...
The American Diabetes Association (ADA)’s Standards of Care — 2025 offer new guidance on broader use of continuous glucose monitoring (CGM), use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs ...
For the second year, the American Diabetes Association and The Leapfrog Group are recognizing leading hospitals for patient safety in diabetes care. Of the 36 health care providers across 12 states ...
Wider use of continuous glucose monitoring (CGM), glycemic management during cancer treatment, and individualized dosing of obesity drugs in people with diabetes are just a few of the new topics and ...
New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful ...
Biomea Fusion presented positive data on icovamenib for type 2 diabetes, showing improved glycemic control and weight loss in clinical trials. Biomea Fusion announced promising new data for icovamenib ...
iRhythm Technologies reports high prevalence of cardiac arrhythmias in type 2 diabetes patients associated with chronic kidney disease, highlighting early detection importance. iRhythm Technologies, ...
UAB Comprehensive Diabetes Center (UCDC) scientist Kirk Habegger, Ph.D., is featured in the Diabetes Spotlight in the May 2025 issue of Diabetes, the flagship research publication of the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results